Correspondence 0001213900-24-081436 from Raphael Pharmaceutical Inc. (RAPH) (CIK 0001415397) (RAPH)
Raphael Pharmaceutical Inc. (RAPH) (CIK 0001415397)
Date: Sept. 24, 2024 · CIK: 0001415397 · Accession: 0001213900-24-081436
AI Filing Summary & Sentiment
File numbers found in text: 333-282104
Letter
Raphael Pharmaceutical Inc.
4 Lui Paster
Tel Aviv-Jaffa, Israel 6803605
September 24, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE: Raphael Pharmaceutical Inc. (CIK 0001415397)
Registration Statement on Form S-1
File No. 333-282104
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Raphael Pharmaceutical Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 4:15 p.m., Eastern Time, on September 26, 2024, or as soon as practicable thereafter.
The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson of Sullivan & Worcester LLP at (212) 660 3092 and that such effectiveness also be confirmed in writing.
Very truly yours,
Raphael Pharmaceutical Inc.
Show Raw Text
CORRESP
1
filename1.htm
Raphael Pharmaceutical Inc.
4 Lui Paster
Tel Aviv-Jaffa, Israel 6803605
September 24, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE: Raphael Pharmaceutical Inc. (CIK 0001415397)
Registration Statement on Form S-1
File No. 333-282104
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended (the “Securities Act”), Raphael Pharmaceutical Inc. (the “Registrant”)
hereby requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective
at 4:15 p.m., Eastern Time, on September 26, 2024, or as soon as practicable thereafter.
The Registrant understands
that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed
public offering of the securities specified in the Registration Statement.
The Registrant respectfully
requests that it be notified of such effectiveness by a telephone call to Eric Victorson of Sullivan & Worcester LLP at (212) 660
3092 and that such effectiveness also be confirmed in writing.
Very truly yours,
Raphael Pharmaceutical Inc.
By:
/s/ Shlomo Pilo
Name:
Shlomo Pilo
Title:
Chief Executive Officer